These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7594800)

  • 1. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
    Fukuyama M; Kawakami K; Suda O; Imagawa Y
    Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
    Fukuyama M; Oonaka K; Hara M; Imagawa Y
    Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
    Imagawa Y; Fukuyama M; Kawakami K; Suda O
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
    Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
    Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
    Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [clinical study of balofloxacin on infectious enteritis and assessment of the fecal drug concentration and intestinal microbial flora in patients with inpatients with infectious enteritis. Research group of balofloxacin on infectious enteritis].
    Obana M; Irimajiri S; Tomizawa I; Takizawa Y; Sakamoto Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G
    Kansenshogaku Zasshi; 1995 Sep; 69(9):991-1006. PubMed ID: 7594801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of norfloxacin (NFLX) against enteritis-causing bacteria].
    Goto N; Horiuchi S; Okamura N; Inagaki Y; Ozawa K; Mochizuki A; Nakaya R
    Kansenshogaku Zasshi; 1986 Apr; 60(4):315-21. PubMed ID: 3095460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
    Yamane N; Chilima BZ; Tosaka M; Okazawa Y; Tanno K
    Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
    Sagara H; Yoshikawa K; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Matsumoto F; Imai T; Sakurai I; Takahashi T; Mori M; Mizuno Y; Katoh K; Hosoda S; Bamba T; Saito M
    Kansenshogaku Zasshi; 1996 Jan; 70(1):60-72. PubMed ID: 8822054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Shimizu N; Tomizawa I; Takizawa Y; Nitia Y; Seo T; Kamimura M; Kanehisa N
    Kansenshogaku Zasshi; 1989 Jul; 63(7):659-75. PubMed ID: 2693543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
    Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1390-408. PubMed ID: 7829908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I; Verbist L; Vandepitte J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
    Le Noc P; Croizé J; Le Noc D
    Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of susceptibilities of Campylobacter jejuni isolated from diarrhoeal cases to fluoroquinolones in Tokyo].
    Tadano K; Shingaki M; Saito K; Takahashi M; Kai A; Yanagawa Y; Itoh T; Ohta K; Kudoh Y
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1227-33. PubMed ID: 9011115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
    Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A
    Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Chida T; Nakaya R
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.